JANUARY
2020
"You are unique - and so is your treatment"
+49 7443 964240
JANUARY
NEWS
January 2020
January 2020 - Up2Date in HER2-positive breast cancer: New therapy strategy available
The FDA has granted an accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu; DS-8201) for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer.
Share on:
17. March 2020
We would like to share with you a comment in regard to the corona virus pandemia. Due to the current events, more information should be highlighted relating to our field of medicine
03. December 2020
FDA Pipeline: Agents in DLBCL, SCLC, AML, and More
Contact us
Contact us for a free consultation with our specialized oncology team.
Silberwaldstraße 34
72280 Dornstetten /
Hallwangen, Germany
72280 Dornstetten /
Hallwangen, Germany
Office:
+49 7443 964240
E-Mail:
Time:
Mo - Fr: 08:00 - 19:00
Sa: 09:00 -13:00
Sa: 09:00 -13:00